\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\)\\ \\ ap\\ knee\\:\\ chondrocalcinosis\\ demonstrated\\ by\\ wedge\\ shaped\\ calcification\\ seen\\ in\\ the\\ fibrocartilaginous\\ menisci\\ and\\ curvilinear\\ calcification\\ of\\ the\\ hyaline\\ cartilage\\ seen\\ best\\ on\\ the\\ medial\\ aspect\\ of\\ lateral\\ femoral\\ condyle\\.\\ calcification\\ of\\ the\\ cruciate\\ ligaments\\ is\\ also\\ appreciated\\.\\ the\\ medial\\ and\\ lateral\\ tibio\\-femoral\\ joint\\ spaces\\ remain\\ preserved\\.\ \(0\)\
\-\ 2\\.\\)\\ lateral\\ knee\\:\\ the\\ femoro\\-patellar\\ joint\\ space\\ is\\ preserved\\ with\\ minimal\\ subchondral\\ sclerosis\\.\\ curvilinear\\ calcification\\ in\\ the\\ hyaline\\ cartilage\\ of\\ the\\ medial\\ and\\ lateral\\ femoral\\ condyles\\ and\\ \\ the\\ calcified\\ menisci\\ are\\ also\\ seen\\.\ \(0\)\
\-\ 3\\.\\)\\ left\\ hip\\:\\ uniform\\ narrowing\\ of\\ joint\\ space\\ with\\ axial\\ migration\\ of\\ femoral\\ head\\.\\ numerous\\ subchondral\\ cysts\\.mild\\ degenerative\\ change\\ with\\ osteophyte\\ formation\ \(0\)\
\-\ 4\\.\\)\\ right\\ hip\\:\\ joint\\ space\\ preserved\\.\\ calcinosis\\ of\\ femoral\\ hyaline\\ cartilage\\.\\ sclerotic\\ changes\\ in\\ acetabulum\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ crystal\\ deposition\\ disease\\ \\(cppd\\)\\ \\(pseudogout\\)\ \(0\)\
\-\ 1\\.\\)\\ cation\\ disease\ \(0\)\
\-\ 2\\.\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ 3\\.\\)\\ cartilage\\ degeneration\\ from\\ unknown\\ cause\\.\ \(0\)\
\-\ 61yo\\ caucasian\\ male\\ with\\ 4\\-5\\ year\\ history\\ of\\ intermittent\\ acute\\ episodes\\ of\\ swollen\\,\\ red\\,\\ painful\\ knees\\ and\\ left\\ hip\\.\\ episodes\\ of\\ pain\\ last\\ 1\\-2\\ weeks\\ and\\ are\\ usually\\ relieved\\ with\\ nsaids\\.\ \(0\)\
\-\ cppd\\ may\\ produce\\ the\\ clinical\\ symtoms\\ and\\ findings\\ of\\ pseudogout\\ and\\ occurs\\ usually\\ in\\ persons\\ \\ over\\ age\\ 50\\ with\\ no\\ gender\\ preference\\.\\ some\\ studies\\ show\\ its\\ prevalence\\ to\\ 3\\-5\\%\\ of\\ the\\ adult\\ population\\ as\\ demonstrated\\ by\\ calcium\\ pyrophosphate\\ dihydrate\\ deposits\\ in\\ the\\ knee\\ joint\\ making\\ it\\ the\\ most\\ common\\ crystal\\ arthropathy\\.\\ however\\,\\ it\\ is\\ estimated\\ that\\ there\\ is\\ only\\ one\\ symptomatic\\ patient\\ for\\ every\\ 2\\-3\\ patients\\ with\\ gouty\\ arthritis\\.\ \(0\)\
\-\ when\\ chondrocalcinosis\\ is\\ identified\\ the\\ differential\\ diagnosis\\ is\\ relatively\\ short\\.\\ it\\ is\\ essentially\\ the\\ 3\\ c\\'s\\ 1\\)\\ cation\\ disease\\,\\ 2\\)\\ crystal\\ deposition\\ disease\\,\\ 3\\)\\ cartilage\\ degeneration\\ from\\ unknown\\ cause\\.\ \(0\)\
\-\ cation\\ diseases\\ includes\\ 1\\)\\ hyperparathyroidism\\,\\ 2\\)\\ hemochromatosis\\,\\ 3\\)\\ wilson\\'s\\ disease\\.\\ approximately\\ 30\\-50\\%\\ of\\ patients\\ with\\ hyperparathyroidism\\ or\\ hemochromatosis\\ have\\ arthropathy\\ secondary\\ to\\ calcium\\ pyrophosphate\\ deposits\\.\\ it\\ is\\ thought\\ that\\ high\\ concentrations\\ of\\ these\\ ions\\ inhibits\\ the\\ normal\\ hydrolysis\\ of\\ calcium\\ pyrophosphate\\ leading\\ to\\ crystal\\ formation\\ and\\ deposition\\.\\ wilson\\'s\\ disease\\ is\\ rare\\ and\\ the\\ neurologic\\ symptoms\\ far\\ outweigh\\ the\\ joint\\ manifestations\\ but\\ it\\ is\\ associated\\ with\\ chondrocalcinosis\\.\ \(0\)\
\-\ crystal\\ deposition\\ disease\\ included\\ gout\\ \\(sodium\\ monourate\\)\\ or\\ pseudogout\\ \\(calcium\\ pyrophosphate\\)\\ crystals\\ in\\ the\\ joint\\ space\\.\\ the\\ crystals\\ are\\ irritating\\ and\\ clinically\\ both\\ of\\ these\\ diseases\\ can\\ present\\ similarly\\.\\ identifying\\ an\\ associated\\ effusion\\ and\\ chondrocalcinosis\\ makes\\ cppd\\ more\\ likely\\.\\ examination\\ of\\ the\\ synovial\\ fluid\\ confirms\\ the\\ diagnosis\\.\\ under\\ polarized\\ light\\ the\\ calcium\\ pyrophosphate\\ crystals\\ are\\ short\\ blunt\\ rods\\ rhomboids\\ and\\ cuboids\\ and\\ have\\ weakly\\ positive\\ birefringence\\.\\ the\\ sodium\\ urate\\ crystals\\ are\\ needle\\ shaped\\ and\\ show\\ strongly\\ negative\\ birefringence\\.\\ cppd\\ most\\ commonly\\ affects\\ the\\ knee\\,\\ wrist\\ pubic\\ symphysis\\.\\ in\\ a\\ patient\\ with\\ cppd\\ at\\ least\\ one\\ of\\ these\\ areas\\ will\\ be\\ affected\\.\\ a\\ presumptive\\ radiologic\\ diagnosis\\ may\\ be\\ made\\ if\\ two\\ or\\ more\\ skeletal\\ areas\\ show\\ chondrocalcinosis\\.\ \(0\)\
\-\ the\\ other\\ forms\\ of\\ cartilage\\ degeneration\\ are\\ often\\ associated\\ with\\ calcium\\ hydroxyapatite\\.\\ these\\ crystals\\ are\\ deposited\\ in\\ the\\ tendons\\ and\\ joint\\ soft\\ tissues\\.\\ it\\ is\\ associated\\ with\\ unusually\\ high\\ levels\\ of\\ collagenase\\.\ \(0\)\
\-\ ochronosis\\ is\\ another\\ disease\\ associated\\ with\\ calcium\\ hydroxyapatite\\.\\ the\\ cartilage\\ destruction\\ comes\\ from\\ the\\ underlying\\ metabolic\\ disorder\\ absent\\ homogentisic\\ acid\\ oxidase\\.\\ this\\ excess\\ homogentisic\\ acid\\ is\\ deposited\\ in\\ the\\ cartilage\\.\\ it\\ is\\ associated\\ with\\ osteoporosis\\,\\ multiple\\ level\\ disc\\ degeneration\\,\\ loss\\ of\\ joint\\ space\\,\\ and\\ intra\\-articular\\ loose\\ bodies\\.\\ the\\ spine\\ is\\ most\\ frequently\\ affected\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cartilage\\:\\ 0\\.05727627145248924\ \(0\)\
\-\ crystal\\:\\ 0\\.05622981787838171\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.05575841532602004\ \(0\)\
\-\ calcium\\:\\ 0\\.05385880110450064\ \(0\)\
\-\ crystals\\:\\ 0\\.04972996050202286\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.0464653461050167\ \(0\)\
\-\ cppd\\:\\ 0\\.04332955893302216\ \(0\)\
\-\ cation\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ joint\\:\\ 0\\.04004969934843596\ \(0\)\
\-\ deposition\\:\\ 0\\.03842566148254386\ \(0\)\
\-\ pseudogout\\:\\ 0\\.032541434213945224\ \(0\)\
\-\ hyaline\\:\\ 0\\.029504677405141486\ \(0\)\
\-\ deposited\\:\\ 0\\.028391363684272135\ \(0\)\
\-\ homogentisic\\:\\ 0\\.028391363684272135\ \(0\)\
\-\ degeneration\\:\\ 0\\.027943198772871443\ \(0\)\
\-\ birefringence\\:\\ 0\\.02615900561483592\ \(0\)\
\-\ preserved\\:\\ 0\\.024416996658323357\ \(0\)\
\-\ space\\:\\ 0\\.022758107947476926\ \(0\)\
\-\ it\\:\\ 0\\.02165207518797281\ \(0\)\
\-\ femoral\\:\\ 0\\.02094040590430792\ \(0\)\
\-\ dihydrate\\:\\ 0\\.020668673594744374\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.020668673594744374\ \(0\)\
\-\ disease\\:\\ 0\\.020242573061097162\ \(0\)\
\-\ calcification\\:\\ 0\\.01997929544899922\ \(0\)\
\-\ knee\\:\\ 0\\.019958072287022715\ \(0\)\
\-\ \\)\\:\\ 0\\.019533237948351347\ \(0\)\
\-\ associated\\:\\ 0\\.01948273006674108\ \(0\)\
\-\ menisci\\:\\ 0\\.019082597958358562\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.019082597958358562\ \(0\)\
\-\ wilson\\:\\ 0\\.018436315525308156\ \(0\)\
\-\ sodium\\:\\ 0\\.018293153649073586\ \(0\)\
\-\ deposits\\:\\ 0\\.0177767521995561\ \(0\)\
\-\ hip\\:\\ 0\\.016443827884596415\ \(0\)\
\-\ acid\\:\\ 0\\.016131581108522315\ \(0\)\
\-\ 3\\:\\ 0\\.016110914063659738\ \(0\)\
\-\ curvilinear\\:\\ 0\\.015857320856218587\ \(0\)\
\-\ arthropathy\\:\\ 0\\.015485298675471907\ \(0\)\
\-\ subchondral\\:\\ 0\\.01444375228238379\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.01444375228238379\ \(0\)\
\-\ these\\:\\ 0\\.01432428142968013\ \(0\)\
\-\ tibio\\-femoral\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ femoro\\-patellar\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ cysts\\.mild\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ 61yo\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ ions\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ hydrolysis\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ monourate\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ polarized\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ rhomboids\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ cuboids\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ collagenase\\:\\ 0\\.014195681842136067\ \(0\)\
\-\ shaped\\:\\ 0\\.01400840678039264\ \(0\)\
\-\ diseases\\:\\ 0\\.013863635804990816\ \(0\)\
\-\ episodes\\:\\ 0\\.013592265938267015\ \(0\)\
\-\ is\\:\\ 0\\.013581902859534435\ \(0\)\
\-\ medial\\:\\ 0\\.013204345476280443\ \(0\)\
\-\ are\\:\\ 0\\.013130623361847362\ \(0\)\
\-\ 1\\:\\ 0\\.013097110260610029\ \(0\)\
\-\ irritating\\:\\ 0\\.01307950280741796\ \(0\)\
\-\ oxidase\\:\\ 0\\.01307950280741796\ \(0\)\
\-\ short\\:\\ 0\\.012972710728452344\ \(0\)\
\-\ show\\:\\ 0\\.012672250891263894\ \(0\)\
\-\ fibrocartilaginous\\:\\ 0\\.012426579928016728\ \(0\)\
\-\ symtoms\\:\\ 0\\.012426579928016728\ \(0\)\
\-\ 30\\-50\\:\\ 0\\.011963323772699852\ \(0\)\
\-\ weakly\\:\\ 0\\.011963323772699852\ \(0\)\
\-\ urate\\:\\ 0\\.011963323772699852\ \(0\)\
\-\ ochronosis\\:\\ 0\\.011963323772699852\ \(0\)\
\-\ affected\\:\\ 0\\.011908291824636855\ \(0\)\
\-\ lateral\\:\\ 0\\.011894802226245092\ \(0\)\
\-\ 2\\:\\ 0\\.011852524937265997\ \(0\)\
\-\ persons\\:\\ 0\\.011603994382499835\ \(0\)\
\-\ preference\\:\\ 0\\.011603994382499835\ \(0\)\
\-\ outweigh\\:\\ 0\\.011603994382499835\ \(0\)\
\-\ formation\\:\\ 0\\.0113599078688308\ \(0\)\
\-\ inhibits\\:\\ 0\\.011062171135122681\ \(0\)\
\-\ unknown\\:\\ 0\\.010740352659016125\ \(0\)\
\-\ calcinosis\\:\\ 0\\.010657478013897388\ \(0\)\
\-\ concentrations\\:\\ 0\\.010657478013897388\ \(0\)\
\-\ unusually\\:\\ 0\\.010657478013897388\ \(0\)\
\-\ rods\\:\\ 0\\.010194221858580512\ \(0\)\
\-\ condyles\\:\\ 0\\.010065328609508794\ \(0\)\
\-\ gouty\\:\\ 0\\.010065328609508794\ \(0\)\
\-\ 3\\-5\\:\\ 0\\.009945992100404573\ \(0\)\
\-\ similarly\\:\\ 0\\.009945992100404573\ \(0\)\
\-\ symphysis\\:\\ 0\\.009633341513543128\ \(0\)\
\-\ most\\:\\ 0\\.009530604549410996\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009479320438552753\ \(0\)\
\-\ presumptive\\:\\ 0\\.009371636313063618\ \(0\)\
\-\ cause\\:\\ 0\\.009311634868122275\ \(0\)\
\-\ areas\\:\\ 0\\.009260377363111326\ \(0\)\
\-\ gender\\:\\ 0\\.009218157762654078\ \(0\)\
\-\ excess\\:\\ 0\\.009218157762654078\ \(0\)\
\-\ 4\\-5\\:\\ 0\\.009146576824536793\ \(0\)\
\-\ \\'s\\:\\ 0\\.00910167448486495\ \(0\)\
\-\ comes\\:\\ 0\\.009012306922863603\ \(0\)\
\-\ cruciate\\:\\ 0\\.008829813065686464\ \(0\)\
\-\ pubic\\:\\ 0\\.008829813065686464\ \(0\)\
\-\ wedge\\:\\ 0\\.008773305304315658\ \(0\)\
\-\ osteophyte\\:\\ 0\\.008718713433662387\ \(0\)\
\-\ identifying\\:\\ 0\\.008614786668545526\ \(0\)\
\-\ intra\\-articular\\:\\ 0\\.008614786668545526\ \(0\)\
\-\ acetabulum\\:\\ 0\\.00851716247882502\ \(0\)\
\-\ prevalence\\:\\ 0\\.008470483675486449\ \(0\)\
\-\ tendons\\:\\ 0\\.008380999213079346\ \(0\)\
\-\ usually\\:\\ 0\\.008357256856253652\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.008338055175910004\ \(0\)\
\-\ blunt\\:\\ 0\\.00821569461716939\ \(0\)\
\-\ seen\\:\\ 0\\.00815762132882942\ \(0\)\
\-\ migration\\:\\ 0\\.008138998886107786\ \(0\)\
\-\ relieved\\:\\ 0\\.00810197872793597\ \(0\)\
\-\ demonstrated\\:\\ 0\\.008075426674579606\ \(0\)\
\-\ uniform\\:\\ 0\\.008065790554261158\ \(0\)\
\-\ knees\\:\\ 0\\.007995766219414557\ \(0\)\
\-\ forms\\:\\ 0\\.007995766219414557\ \(0\)\
\-\ loose\\:\\ 0\\.007995766219414557\ \(0\)\
\-\ estimated\\:\\ 0\\.007961863789144296\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.007896127888145494\ \(0\)\
\-\ synovial\\:\\ 0\\.007896127888145494\ \(0\)\
\-\ manifestations\\:\\ 0\\.007832970540072577\ \(0\)\
\-\ affects\\:\\ 0\\.007832970540072577\ \(0\)\
\-\ far\\:\\ 0\\.007772197065059942\ \(0\)\
\-\ remain\\:\\ 0\\.007713634030968355\ \(0\)\
\-\ essentially\\:\\ 0\\.007713634030968355\ \(0\)\
\-\ gout\\:\\ 0\\.007713634030968355\ \(0\)\
\-\ ligaments\\:\\ 0\\.007685132296508773\ \(0\)\
\-\ strongly\\:\\ 0\\.007657126269597551\ \(0\)\
\-\ produce\\:\\ 0\\.007629599001708178\ \(0\)\
\-\ making\\:\\ 0\\.007629599001708178\ \(0\)\
\-\ makes\\:\\ 0\\.007629599001708178\ \(0\)\
\-\ high\\:\\ 0\\.007531549311036443\ \(0\)\
\-\ one\\:\\ 0\\.007458072087956986\ \(0\)\
\-\ nsaids\\:\\ 0\\.007424840265016961\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.007424840265016961\ \(0\)\
\-\ condyle\\:\\ 0\\.007331463038526865\ \(0\)\
\-\ swollen\\:\\ 0\\.007331463038526865\ \(0\)\
\-\ every\\:\\ 0\\.007308940909743065\ \(0\)\
\-\ confirms\\:\\ 0\\.007308940909743065\ \(0\)\
\-\ \\:\\:\\ 0\\.007280353082065475\ \(0\)\
\-\ red\\:\\ 0\\.007180047660671347\ \(0\)\
\-\ population\\:\\ 0\\.007180047660671347\ \(0\)\
\-\ radiologic\\:\\ 0\\.007159533931561155\ \(0\)\
\-\ patients\\:\\ 0\\.007122623508425204\ \(0\)\
\-\ needle\\:\\ 0\\.00700420339019632\ \(0\)\
\-\ the\\:\\ 0\\.006901333052838003\ \(0\)\
\-\ adult\\:\\ 0\\.006896809872485092\ \(0\)\
\-\ least\\:\\ 0\\.006896809872485092\ \(0\)\
\-\ more\\:\\ 0\\.006883015488928072\ \(0\)\
\-\ skeletal\\:\\ 0\\.006796132969133508\ \(0\)\
\-\ destruction\\:\\ 0\\.006796132969133508\ \(0\)\
\-\ metabolic\\:\\ 0\\.006796132969133508\ \(0\)\
\-\ spaces\\:\\ 0\\.006779948853427386\ \(0\)\
\-\ appreciated\\:\\ 0\\.00670138176136711\ \(0\)\
\-\ leading\\:\\ 0\\.006583141071262733\ \(0\)\
\-\ caucasian\\:\\ 0\\.0065689532617906644\ \(0\)\
\-\ painful\\:\\ 0\\.006540947234879442\ \(0\)\
\-\ c\\:\\ 0\\.006540947234879442\ \(0\)\
\-\ bodies\\:\\ 0\\.006446592703050049\ \(0\)\
\-\ light\\:\\ 0\\.00642061946322737\ \(0\)\
\-\ \\%\\:\\ 0\\.006419713472934002\ \(0\)\
\-\ disc\\:\\ 0\\.006407788272165894\ \(0\)\
\-\ wrist\\:\\ 0\\.006357462115154453\ \(0\)\
\-\ included\\:\\ 0\\.006345122545515856\ \(0\)\
\-\ thought\\:\\ 0\\.00633287681381663\ \(0\)\
\-\ degenerative\\:\\ 0\\.006238125606050232\ \(0\)\
\-\ disorder\\:\\ 0\\.006181617844679427\ \(0\)\
\-\ numerous\\:\\ 0\\.0061705504062128215\ \(0\)\
\-\ sclerotic\\:\\ 0\\.006159558513989955\ \(0\)\
\-\ from\\:\\ 0\\.006118046923450301\ \(0\)\
\-\ in\\:\\ 0\\.006107206233916738\ \(0\)\
\-\ may\\:\\ 0\\.006036484279865133\ \(0\)\
\-\ clinically\\:\\ 0\\.006033195204100269\ \(0\)\
\-\ under\\:\\ 0\\.006013066117523406\ \(0\)\
\-\ absent\\:\\ 0\\.005963817448647271\ \(0\)\
\-\ frequently\\:\\ 0\\.005963817448647271\ \(0\)\
\-\ have\\:\\ 0\\.005959542925491439\ \(0\)\
\-\ another\\:\\ 0\\.0059160303823894336\ \(0\)\
\-\ calcified\\:\\ 0\\.00590664081667157\ \(0\)\
\-\ intermittent\\:\\ 0\\.00590664081667157\ \(0\)\
\-\ underlying\\:\\ 0\\.005897305683524507\ \(0\)\
\-\ relatively\\:\\ 0\\.0058880243554782115\ \(0\)\
\-\ last\\:\\ 0\\.0058787962158502165\ \(0\)\
\-\ arthritis\\:\\ 0\\.0058787962158502165\ \(0\)\
\-\ best\\:\\ 0\\.0057893117534431136\ \(0\)\
\-\ neurologic\\:\\ 0\\.005746367716273772\ \(0\)\
\-\ levels\\:\\ 0\\.0056799539344154\ \(0\)\
\-\ occurs\\:\\ 0\\.005647746741651036\ \(0\)\
\-\ tissues\\:\\ 0\\.005647746741651036\ \(0\)\
\-\ includes\\:\\ 0\\.005547311426471554\ \(0\)\
\-\ narrowing\\:\\ 0\\.00551762752681159\ \(0\)\
\-\ made\\:\\ 0\\.005481275961532139\ \(0\)\
\-\ symptomatic\\:\\ 0\\.005466962036544625\ \(0\)\
\-\ also\\:\\ 0\\.005425505937746059\ \(0\)\
\-\ minimal\\:\\ 0\\.005417842142352331\ \(0\)\
\-\ change\\:\\ 0\\.005363480660991696\ \(0\)\
\-\ rare\\:\\ 0\\.005343559096092265\ \(0\)\
\-\ 50\\:\\ 0\\.00523510147607698\ \(0\)\
\-\ effusion\\:\\ 0\\.005228943510797748\ \(0\)\
\-\ its\\:\\ 0\\.005192482195580743\ \(0\)\
\-\ commonly\\:\\ 0\\.005192482195580743\ \(0\)\
\-\ studies\\:\\ 0\\.005139292943283671\ \(0\)\
\-\ ap\\:\\ 0\\.005032462108925021\ \(0\)\
\-\ sclerosis\\:\\ 0\\.004942536607771892\ \(0\)\
\-\ and\\:\\ 0\\.004927782765616286\ \(0\)\
\-\ identified\\:\\ 0\\.00491701616938216\ \(0\)\
\-\ or\\:\\ 0\\.004838274149583128\ \(0\)\
\-\ \\,\\:\\ 0\\.004795186345716846\ \(0\)\
\-\ that\\:\\ 0\\.0047535611225727\ \(0\)\
\-\ \\(\\:\\ 0\\.004652893566788151\ \(0\)\
\-\ by\\:\\ 0\\.004582514986295893\ \(0\)\
\-\ spine\\:\\ 0\\.004531567706932927\ \(0\)\
\-\ positive\\:\\ 0\\.004465194187253006\ \(0\)\
\-\ often\\:\\ 0\\.004390456599870616\ \(0\)\
\-\ differential\\:\\ 0\\.004368695377379919\ \(0\)\
\-\ aspect\\:\\ 0\\.004322531295464343\ \(0\)\
\-\ will\\:\\ 0\\.00430512241284886\ \(0\)\
\-\ examination\\:\\ 0\\.004277653841343905\ \(0\)\
\-\ approximately\\:\\ 0\\.004257355598318169\ \(0\)\
\-\ be\\:\\ 0\\.00424398300593858\ \(0\)\
\-\ clinical\\:\\ 0\\.004233993236821263\ \(0\)\
\-\ age\\:\\ 0\\.004188261393791154\ \(0\)\
\-\ some\\:\\ 0\\.004178628428126826\ \(0\)\
\-\ only\\:\\ 0\\.004137538902552231\ \(0\)\
\-\ negative\\:\\ 0\\.004109694301730876\ \(0\)\
\-\ loss\\:\\ 0\\.003994306235859001\ \(0\)\
\-\ level\\:\\ 0\\.003966004875437894\ \(0\)\
\-\ changes\\:\\ 0\\.003943716547882545\ \(0\)\
\-\ when\\:\\ 0\\.003940952073455726\ \(0\)\
\-\ two\\:\\ 0\\.003940952073455726\ \(0\)\
\-\ of\\:\\ 0\\.003939742055970623\ \(0\)\
\-\ axial\\:\\ 0\\.003927200444553738\ \(0\)\
\-\ fluid\\:\\ 0\\.003910852020296059\ \(0\)\
\-\ weeks\\:\\ 0\\.003905439222063041\ \(0\)\
\-\ head\\:\\ 0\\.0039027396305537777\ \(0\)\
\-\ likely\\:\\ 0\\.0038813042929720714\ \(0\)\
\-\ secondary\\:\\ 0\\.003847069189225133\ \(0\)\
\-\ 4\\:\\ 0\\.003834093245054823\ \(0\)\
\-\ however\\:\\ 0\\.0038315105565170215\ \(0\)\
\-\ if\\:\\ 0\\.0037338863667965142\ \(0\)\
\-\ common\\:\\ 0\\.003601074415388723\ \(0\)\
\-\ both\\:\\ 0\\.0035140096468375547\ \(0\)\
\-\ over\\:\\ 0\\.0035034502256682167\ \(0\)\
\-\ symptoms\\:\\ 0\\.0034294001238295317\ \(0\)\
\-\ acute\\:\\ 0\\.003397551254599831\ \(0\)\
\-\ soft\\:\\ 0\\.0033509287664952496\ \(0\)\
\-\ other\\:\\ 0\\.003171720690342107\ \(0\)\
\-\ can\\:\\ 0\\.0031211310023656516\ \(0\)\
\-\ present\\:\\ 0\\.0031079045957031898\ \(0\)\
\-\ left\\:\\ 0\\.0030792440234232357\ \(0\)\
\-\ but\\:\\ 0\\.002934787924369626\ \(0\)\
\-\ findings\\:\\ 0\\.002928883954573204\ \(0\)\
\-\ multiple\\:\\ 0\\.002898238330884491\ \(0\)\
\-\ patient\\:\\ 0\\.0027587501800849855\ \(0\)\
\-\ with\\:\\ 0\\.002637775306374326\ \(0\)\
\-\ \\.\\:\\ 0\\.002572430151981614\ \(0\)\
\-\ male\\:\\ 0\\.0024882536841988297\ \(0\)\
\-\ normal\\:\\ 0\\.002157185917228826\ \(0\)\
\-\ as\\:\\ 0\\.0020814452590887725\ \(0\)\
\-\ to\\:\\ 0\\.002063130958661769\ \(0\)\
\-\ there\\:\\ 0\\.0020478511376247803\ \(0\)\
\-\ an\\:\\ 0\\.0019028419714729949\ \(0\)\
\-\ history\\:\\ 0\\.0019005065019437736\ \(0\)\
\-\ at\\:\\ 0\\.00186435290311052\ \(0\)\
\-\ pain\\:\\ 0\\.0016805284501300076\ \(0\)\
\-\ this\\:\\ 0\\.0015477249811821788\ \(0\)\
\-\ year\\:\\ 0\\.0015396220117116178\ \(0\)\
\-\ right\\:\\ 0\\.0014519029132212828\ \(0\)\
\-\ no\\:\\ 0\\.0013855783425181997\ \(0\)\
\-\ a\\:\\ 0\\.0012772940477249637\ \(0\)\
\-\ for\\:\\ 0\\.0011740871958819889\ \(0\)\
\-\ on\\:\\ 0\\.0011656860102502867\ \(0\)\
